Downscheduling welcomed

Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. In a decision released on 7 May, the Therapeutic Goods Administration (TGA) scheduling committee decided Sumatriptan would be in Schedule 3 "when in divided oral